There’s another recall to be aware of right now, and it involves nose spray. NeilMed Pharmaceuticals Inc., the manufacturer ...
The U.S. Food and Drug Administration is recalling 89,312 bottles of NasoGel nasal spray because the product might cause ...
The global landscape of neurological health is undergoing a transformative moment with a pioneering nasal spray that could potentially revolutionize Alzheimer‘s disease management. As ...
Almost 100,000 bottles of nasal spray were recalled for a "microbial failure" that led to multiple complaints from customers.
Compared with placebo, zavegepant nasal spray yielded sustained relief of acute pain and function in migraine.
The neffyinSchools program from ARS Pharma will provide eligible public and private K-12 schools in the United States with ...
Medpage Today on MSN4d
Noted Neuroscientist Dies; Nasal Spray for Alzheimer's Disease; Benign MSA Massachusetts man became the first person to try intranasal foralumab under an expanded access program for people with ...
The results? A nasal spray of oxytocin significantly reduced acute feelings of loneliness in participants, especially during group therapy sessions, even months after treatment. In the study ...
The drug is designed to reduce inflammation in the brain and has been used on MS, cancer and migraine headaches.
STATEN ISLAND, N.Y. — The U.S. Food and Drug Administration (FDA) has announced a recall of 89,312 bottles of a popular nasal ...
The FDA’s latest approval of the nasal spray Spravato (esketamine) CIII marks a major shift in how major depressive disorder is managed, allowing people who have tried at least two oral ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback